CorMedix Inc.
CRMD
Rank in Stocks
#12959
CorMedix Inc. is a biopharmaceutical company engaged in the development and... CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
Share Price
$5.47
Last synced: 2026-11-09
Market Cap
$426.36M
Change (1 day)
2.82%
Change (1 year)
-51.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CorMedix Inc. (CRMD)
Category
Healthcare
Operating Margin for CorMedix Inc. (CRMD)
Operating Margin as of November 2026 TTM: 46.95%
According to CorMedix Inc.'s latest financial reports, its current operating margin (TTM) is 46.95%. At the end of 2025 the company had an operating margin of 48.17%.
Operating Margin history for CorMedix Inc. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 46.95% | -2.53% |
| 2025 | 48.17% | -193.66% |
| 2024 | -51.43% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | -46,819.91% | 203.68% |
| 2021 | -15,417.51% | 35.50% |
| 2020 | -11,378.44% | 53.42% |
| 2019 | -7,416.31% | 18.65% |
| 2018 | -6,250.44% | -37.48% |
| 2017 | -9,997.39% | -9.52% |
| 2016 | -11,048.80% | 39.41% |
| 2015 | -7,925.56% | 68.51% |
| 2014 | -4,703.30% | -98.09% |
| 2013 | -245,769.75% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -99.18% |
US
|
|
| -149.01% | -103.17% |
US
|
|
| 25.57% | -99.46% |
AU
|
|
| 31.23% | -99.33% |
BE
|
|
| 29.35% | -99.37% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about CorMedix Inc.'s operating margin
What is CorMedix Inc.'s operating margin?
CorMedix Inc.'s operating margin is 46.95%, as of Nov 2026.
What was CorMedix Inc.'s operating margin in 2025?
In 2025, CorMedix Inc.'s operating margin was 48.17%, compared with -51.43% in 2024.
How has CorMedix Inc.'s operating margin changed since 2020?
From 2020 to 2025, CorMedix Inc.'s operating margin was highest in 2025 (48.17%) and lowest in 2022 (-46,819.91%).
How does CorMedix Inc.'s operating margin compare with similar companies?
CorMedix Inc.'s operating margin (46.95%) is higher than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.